ContraFect

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ContraFect and other ETFs, options, and stocks.

About CFRX

ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. 

CEO
Roger J. Pomerantz
CEORoger J. Pomerantz
Employees
38
Employees38
Headquarters
Yonkers, New York
HeadquartersYonkers, New York
Founded
2008
Founded2008
Employees
38
Employees38

CFRX Key Statistics

Market cap
3.07M
Market cap3.07M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
34.96M
Average volume34.96M
High today
$0.075
High today$0.075
Low today
$0.0634
Low today$0.0634
Open price
$0.0734
Open price$0.0734
Volume
42.41M
Volume42.41M
52 Week high
$4.54
52 Week high$4.54
52 Week low
$0.0634
52 Week low$0.0634

CFRX Earnings

-$0.51
-$0.34
-$0.17
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 23, Pre-Market
ActualExpected Mar 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.